Gaole Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gaole Lin has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Feng Zhu
Zhejiang University
1 shared publication Fengcheng Li
1 shared publicationFuyao Liu
1 shared publicationHanyu Zhang
1 shared publication- Honglin Li
East China Normal University
1 shared publication - Hongning Zhang
College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou 310058, China
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 28 April 2023
- Published by Elsevier in Engineering
- Vol. 27, 37-69
Artificial Intelligence in Pharmaceutical Sciences
- 28 April 2023
- Published by Elsevier in Engineering
- Vol. 27, 37-69
Top Cited PapersOpen AccessArtificial Intelligence in Pharmaceutical Sciences
- Open Access
- 11 December 2022
- Published by Wiley in Advanced Science
- Vol. 10 (4)
Massively Parallel CRISPR‐Based Genetic Perturbation Screening at Single‐Cell Resolution
The clustered regularly interspaced short palindromic repeats (CRISPR)‐based genetic screening has been demonstrated as a powerful approach for unbiased functional genomics research. Single‐cell CRISPR screening (scCRISPR) techniques, which result from the combination of single‐cell toolkits and CRISPR screening, allow dissecting regulatory networks in complex biological systems at unprecedented resolution. These methods allow cells to be perturbed en masse using a pooled CRISPR library, followed by high‐content phenotyping. This is technically accomplished by annotating cells with sgRNA‐specific barcodes or directly detectable sgRNAs. According to the integration of distinct single‐cell technologies, these methods principally fall into four categories: scCRISPR with RNA‐seq, scCRISPR with ATAC‐seq, scCRISPR with proteome probing, and imaging‐based scCRISPR. scCRISPR has deciphered genotype–phenotype relationships, genetic regulations, tumor biological issues, and neuropathological mechanisms. This review provides insight into the technical breakthrough of scCRISPR by systematically summarizing the advancements of various scCRISPR methodologies and analyzing their merits and limitations. In addition, an application‐oriented approach guide is offered to meet researchers’ individualized demands.
- 11 December 2022
- Published by Wiley in Advanced Science
- Vol. 10 (4)
Open AccessMassively Parallel CRISPR‐Based Genetic Perturbation Screening at Single‐Cell Resolution
The clustered regularly interspaced short palindromic repeats (CRISPR)‐based genetic screening has been demonstrated as a powerful approach for unbiased functional genomics research. Single‐cell CRISPR screening (scCRISPR) techniques, which result from the combination of single‐cell toolkits and CRISPR screening, allow dissecting regulatory networks in complex biological systems at unprecedented resolution. These methods allow cells to be perturbed en masse using a pooled CRISPR library, followed by high‐content phenotyping. This is technically accomplished by annotating cells with sgRNA‐specific barcodes or directly detectable sgRNAs. According to the integration of distinct single‐cell technologies, these methods principally fall into four categories: scCRISPR with RNA‐seq, scCRISPR with ATAC‐seq, scCRISPR with proteome probing, and imaging‐based scCRISPR. scCRISPR has deciphered genotype–phenotype relationships, genetic regulations, tumor biological issues, and neuropathological mechanisms. This review provides insight into the technical breakthrough of scCRISPR by systematically summarizing the advancements of various scCRISPR methodologies and analyzing their merits and limitations. In addition, an application‐oriented approach guide is offered to meet researchers’ individualized demands.